Select Publications
Journal articles
2014, 'Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?', Clinical and Translational Immunology, 3, pp. e19, http://dx.doi.org/10.1038/cti.2014.12
,2014, 'Moving away from ritonavir, abacavir, tenofovir, and efavirenz (RATE) - Agents that concern prescribers and patients: A feasibility study and call for a trial', PLoS ONE, 9, pp. e99530, http://dx.doi.org/10.1371/journal.pone.0099530
,2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', MICROBIOLOGY AUSTRALIA, 35, pp. 103 - 104, http://dx.doi.org/10.1071/MA14033
,2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e93333, http://dx.doi.org/10.1371/journal.pone.0093333
,2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, 15, pp. 65 - 76, http://dx.doi.org/10.1111/hiv.12080
,2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, 28, pp. 2480 - 2483, http://dx.doi.org/10.1097/QAD.0000000000000461
,2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X
,2014, 'Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome', Journal of Virology, 88, pp. 12793 - 12801, http://dx.doi.org/10.1128/JVI.02016-14
,2014, 'Global burden of transmitted HIV drug resistance and HIV-exposure categories: A systematic review and meta-analysis', AIDS, 28, pp. 2751 - 2762, http://dx.doi.org/10.1097/QAD.0000000000000494
,2014, 'HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy', Journal of Virology, 88, pp. 3516 - 3526, http://dx.doi.org/10.1128/JVI.03331-13
,2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control', eLife, 3, pp. e03821, http://dx.doi.org/10.7554/eLife.03821
,2014, 'HIV-specific antibody-dependent phagocytosis matures during HIV infection', Immunology and Cell Biology, 92, pp. 679 - 687, http://dx.doi.org/10.1038/icb.2014.42
,2014, 'Human antigen-specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses', European Journal of Immunology, 44, pp. 1644 - 1661, http://dx.doi.org/10.1002/eji.201344102
,2014, 'Impaired Nef function is associated with early control of HIV-1 viremia', Journal of Virology, 88, pp. 10200 - 10213, http://dx.doi.org/10.1128/JVI.01334-14
,2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy', Journal of Infection, 68, pp. 344 - 354, http://dx.doi.org/10.1016/j.jinf.2013.11.016
,2014, 'MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection', Current Opinion in HIV and AIDS, 9, pp. 464 - 471, http://dx.doi.org/10.1097/COH.0000000000000089
,2014, 'NKT cell depletion in humans during early HIV infection', Immunology and Cell Biology, 92, pp. 578 - 590, http://dx.doi.org/10.1038/icb.2014.25
,2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients', Immunology and Cell Biology, 92, pp. 384 - 388, http://dx.doi.org/10.1038/icb.2013.101
,2014, 'Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: An observational cohort study', The Lancet HIV, 1, pp. e119 - e126, http://dx.doi.org/10.1016/S2352-3018(14)00002-2
,2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', Microbiology Australia, 10, pp. 1071
,2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting', AIDS Research and Human Retroviruses, 29, pp. 1621 - 1625, http://dx.doi.org/10.1089/aid.2013.0132
,2013, 'Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection', Retrovirology, 10, http://dx.doi.org/10.1186/1742-4690-10-139
,2013, 'Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0077479
,2013, 'Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+ T Cells Using Qualitative Multiplex Single-Cell RT-PCR', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0074946
,2013, 'The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells', AIDS Research and Human Retroviruses, 29, pp. 1330 - 1339, http://dx.doi.org/10.1089/aid.2012.0351
,2013, 'The search for an HIV cure: Tackling latent infection', The Lancet Infectious Diseases, 13, pp. 614 - 621, http://dx.doi.org/10.1016/S1473-3099(13)70043-4
,2013, 'Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers', AIDS, 27, pp. 519 - 528, http://dx.doi.org/10.1097/QAD.0b013e32835cb720
,2013, 'Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing', Molecular Therapy Nucleic Acids, 2, pp. e137, http://dx.doi.org/10.1038/mtna.2013.64
,2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, 51, pp. 2063 - 2071, http://dx.doi.org/10.1128/JCM.00510-13
,2013, 'The role of T cell immunity in HIV-1 infection', Current Opinion in Virology, 3, pp. 438 - 446, http://dx.doi.org/10.1016/j.coviro.2013.05.009
,2013, 'Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action', PLoS Computational Biology, 9, pp. e1002971 (11pp), http://dx.doi.org/10.1371/journal.pcbi.1002971
,2013, 'Mirnas and HIV: Unforeseen Determinants Of Host-Pathogen Interaction', Immunological Reviews, 254, pp. 265 - 280, http://dx.doi.org/10.1111/imr.12077Document
,2013, 'Short-course antiretroviral therapy in primary HIV infection', New England Journal of Medicine, 368, pp. 207 - 217, http://dx.doi.org/10.1056/NEJMoa1110039
,2013, 'Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques', Journal of Virology, 87, pp. 3760 - 3773, http://dx.doi.org/10.1128/JVI.02497-12
,2013, 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection', European Journal of Immunology, 43, pp. 510 - 520, http://dx.doi.org/10.1002/eji.201242695
,, 2012, 'Track A Basic Science', Journal of the International AIDS Society, 15, http://dx.doi.org/10.7448/ias.15.5.18438
2012, 'Anti-APOBEC3G activity of HIV-1 Vif protein from elite controllers is attenuated compared to those from untreated chronic progressors or those from individuals with acute infection', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Natural control of HIV infection is associated with an isotype switched IgG antibody response to HIV core antigens in patients with 'non-protective' HLA-B alleles', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 5 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Acute HIV infection', , pp. 77 - 88, http://dx.doi.org/10.1016/B978-1-4557-0695-2.00006-7
,2012, 'Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.', Clin Infect Dis, 54, pp. 111 - 118, http://dx.doi.org/10.1093/cid/cir814
,2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008
,2012, 'Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion', Annals of Internal Medicine, 172, pp. 1252 - 1255, http://dx.doi.org/10.1001/archinternmed.2012.2719
,2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection', PLoS One, 7, pp. e31148, http://dx.doi.org/10.1371/journal.pone.0031148
,2012, 'Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity', Journal of Immunological Methods, 384, pp. 51 - 61, http://dx.doi.org/10.1016/j.jim.2012.07.006
,2012, 'Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection', Immunology, 138, pp. 116 - 123, http://dx.doi.org/10.1111/imm.12016
,2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213
,2012, 'The role of microRNAs in HIV-1 pathogenesis and therapy', AIDS, 26, pp. 1325 - 1334, http://dx.doi.org/10.1097/QAD.0b013e328352adca
,2012, 'Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity', Journal of Virology, 86, pp. 6913 - 6923, http://dx.doi.org/10.1128/JVI.07133-11
,2011, 'Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.', AIDS, 25, pp. 1395 - 1403, http://dx.doi.org/10.1097/QAD.0b013e3283489c8b
,2011, 'HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, 85, pp. 4635, http://dx.doi.org/10.1128/JVI.00375-11
,